Elehear Beyond vs Otofonix Encore

The Elehear Beyond is a budget-priced OTC hearing aid that delivers A-grade performance in our lab testing, ranking #8 among 65 OTC hearing aids tested. At $431, this 2024 behind-the-ear device earned our Expert's Choice Award and represents strong value in the entry-level price tier. In our testing, the Beyond demonstrated particular strength in speech clarity in quiet environments, scoring 4.3/5—a strong result that sits 1.48 points above the OTC category average. Music streaming quality also impressed at 3.8/5, exceeding the category average by 1.88 points. Speech understanding in noisy settings scored 2.3/5, which is above the category average of 1.48/5 but remains mixed in absolute terms—a common challenge across OTC devices. Feedback handling proved excellent at 4.5/5, essentially matching the category average. Own-voice comfort scored 2.6/5, slightly above the OTC average but mixed overall—users sensitive to their own voice may notice some occlusion effects. The device uses a rechargeable battery and supports streaming to both iPhone and Android devices with hands-free functionality. The Elehear Beyond is well-suited for budget-conscious consumers seeking reliable speech clarity in quieter listening situations and quality audio streaming. Those who frequently encounter challenging noise environments may find the speech-in-noise performance adequate but not exceptional. Within its price range, the Beyond outperforms competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni on overall sound quality.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.